For formulators in the pharmaceutical and nutraceutical industries, identifying compounds with potent and well-documented anti-inflammatory properties is crucial. Harpagoside (CAS 19210-12-9), a natural extract derived from devil's claw, has emerged as a significant ingredient due to its demonstrated efficacy in modulating inflammatory responses. As a leading manufacturer and supplier of this high-purity compound from China, we are committed to supporting your formulation needs.

Harpagoside's anti-inflammatory mechanisms, including the inhibition of key inflammatory mediators like TNF-α, IL-6, and the suppression of iNOS and COX-2 expression via NF-κB pathways, make it an ideal candidate for developing products aimed at alleviating symptoms associated with inflammatory conditions such as osteoarthritis and general joint pain. Its natural origin also aligns with the growing consumer demand for plant-based health solutions.

When considering Harpagoside for your formulations, quality and consistency are paramount. Our manufacturing process yields Harpagoside with an assay of ≥98%, ensuring a reliable and potent active ingredient. We adhere to strict quality control measures, aligning with USP, BP, and EP standards, which are vital for product safety and efficacy in regulated markets. As a direct manufacturer, we offer competitive pricing and the assurance of a stable supply chain.

We invite formulators and product developers to purchase Harpagoside from us, your trusted partner in China. Whether you require it for a new dietary supplement, a therapeutic drug candidate, or ongoing research, we are equipped to supply you with the highest quality material. Our team is ready to provide detailed product information, certificates of analysis, and to assist with your sample requests and bulk order inquiries. Partner with us to harness the anti-inflammatory power of Harpagoside.